References
- Tao Y, Wu D, Zhou L. et al. Present and future therapies for chronic hepatitis B. Adv Exp Med Biol. 2020;1179:137–186. doi:https://doi.org/10.1007/978-981-13-9151-4_6.
- Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053–2063. doi:https://doi.org/10.1016/S0140-6736(14)60220-8.
- Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci. 2005;2(1):50–57. doi:https://doi.org/10.7150/ijms.2.50.
- Murray PI, Prasad J, Rahi AH. Status of hepatitis B virus in the aetiology of uveitis in Great Britain. Br J Ophthalmol. 1983;67(10):685–687. doi:https://doi.org/10.1136/bjo.67.10.685.
- Köşe Ş, Senger SS, Çavdar G, Ersan G. A case with chronic hepatitis B and anterior uveitis - Is there any connection? J Microbiol Infect Dis. 2011;1(2):78–79. doi:https://doi.org/10.5799/ahinjs.02.2011.02.0019.
- Sood A, Midha V, Sood N, Gupta D. Hepatitis B and pupil-sparing oculomotor nerve paresis. Clin Infect Dis. 1999;29(5):1330–1331. doi:https://doi.org/10.1086/313449.
- Zhao S, Chen T, Peng C. et al. The putative acceleration of optic neuritis when combined with chronic hepatitis B. J Neurol Sci. 2015;358:207–212. doi:https://doi.org/10.1016/j.jns.2015.08.1538.
- Teng D, Tan S, Yang M, et al. A case report of hepatitis B related optic neuritis treated with plasma exchange. Medicine (Baltimore). 2019;98(18):e15432. doi:https://doi.org/10.1097/MD.0000000000015432.
- Curras-Martin D, Campbell N, Haroon A, Hossain MA, Asif A. Recurrent optic neuritis as the only manifestation of chronic hepatitis B virus flare: a case report. J Med Case Rep. 2018 Oct 16;12(1):316. doi:https://doi.org/10.1186/s13256-018-1810-0.
- Achiron LR. Postinfectious hepatitis B optic neuritis. Optom Vis Sci. 1994;71(1):53–56. doi:https://doi.org/10.1097/00006324-199401000-00011.
- Galli M, Morelli R, Casellato A, Perna MC. Retrobulbar optic neuritis in a patient with acute type B hepatitis. J Neurol Sci. 1986;72(2–3):195–200. doi:https://doi.org/10.1016/0022-510X(86)90007-9.
- Farthing CF, Howard RS, Thin RN. Papillitis and hepatitis B. Br Med J (Clin Res Ed). 1986;292(6537):1712. doi:https://doi.org/10.1136/bmj.292.6537.1712.
- Şener AG, Aydın N, Ceylan C, Kırdar S. Kronik hepatit B hastalarında antinükleer antikorların araştırılması [Investigation of antinuclear antibodies in chronic hepatitis B patients]. Mikrobiyol Bul. 2018;52(4):425–430. doi:https://doi.org/10.5578/mb.67262.
- Dalkılıç E, Öksüz MF, Tufan AN, et al. Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers. Eur J Rheumatol. 2015;2(2):62–65. doi:https://doi.org/10.5152/eurjrheum.2015.0101.
- Lee SI, Yoo WH, Yun HJ, et al. Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection. Clin Rheumatol. 2007;26(7):1079–1082. doi:https://doi.org/10.1007/s10067-006-0451-7.